Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 287
  • 288
  • 289
  • …
  • ›
  • »

2026-07-06

"Arms Race Has Started": War Unicorns Enter M&A Phase As Ondas Snaps Up Kamikaze Drone Maker DZYNE

2026-07-06

Abivax Announces Closing of $920 Million Public Offering

2026-07-06

Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering

2026-07-06

Encore Capital Group to Announce Second Quarter 2026 Financial Results on August 5

2026-07-06

PennantPark Investment Corporation Schedules Earnings Release of Third Fiscal Quarter 2026 Results

2026-07-06

Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes

2026-07-06

CrowdStrike extends rally to seven sessions after stock split

2026-07-06

BP′s interim chair Tyler considers bid for permanent role - Sky News

2026-07-06

McFarlane Lake Announces C$6.2 Million in Warrant Exercises

2026-07-06

Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection

2026-07-06

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-07-06

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

  • «
  • ‹
  • …
  • 287
  • 288
  • 289
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies